Quick Answer
Benitec Biopharma Inc. reported Total Assets of $99.59 million for fiscal year 2025.
Benitec Biopharma Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $99.59M | +90.8% |
| 2024 | $52.21M | +1069.6% |
| 2023 | $4.46M | -25.3% |
| 2022 | $5.97M | -72.1% |
| 2021 | $21.38M | +84.5% |
| 2020 | $11.59M | -39.8% |
| 2019 | $19.23M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $190.68M | +141.2% | +98.6% |
| September 30, 2025 | $96.03M | +39.6% | -3.6% |
| June 30, 2025 | $99.59M | +90.8% | -5.3% |
| March 31, 2025 | $105.21M | +601.4% | +33.1% |
| December 31, 2024 | $79.07M | +270.3% | +15.0% |
| September 30, 2024 | $68.77M | +154.2% | +31.7% |
| June 30, 2024 | $52.21M | +1069.6% | +248.1% |
| March 31, 2024 | $15.00M | +82.5% | -29.8% |
- Benitec Biopharma Inc. showed an increase of +90.8% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Benitec Biopharma Inc.’s total assets has grown by 417.8% (from $19.23 million to $99.59 million).
- The most recent figure is from Benitec Biopharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: